Psychological response to growth hormone treatment in short normal children.

A B Downie, J Mulligan, E S McCaughey, R J Stratford, P R Betts, L D Voss

Department of Child Health, Southampton University Hospitals Trust.

This study provides a controlled assessment of the psychological (and physical) effects of growth hormone treatment. Fifteen short 'normal' children (height SD score < -2) have been treated with growth hormone since the age of 7/8 years. They, together with untreated short controls and average controls (10th-90th centiles), were assessed at recruitment, after three years, and after five years. Only the treated group showed a significant height increase (SD score -2.44 to -1.21 over five years). No significant differences were found at recruitment, three years, or five years in IQ, attainment, behaviour, or self esteem. Also at five years, there were no significant differences in locus of control, self perception, or parental perceptions of competence. Both short groups displayed less satisfaction with their height than the controls (p < 0.01), though all groups were optimistic of being tall adults. The treated children were no more unrealistic over final height than the untreated children. To date, no psychological benefits of treatment have been demonstrated; but nor have there been any discernible ill effects for either the treated or the untreated children.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Dunkel, L. (2006). Management of children with idiopathic short stature. Eur J Endocrinol 155: S35-S38 [Abstract] [Full Text]  
• Voss, L. D (2006). Is short stature a problem? The psychological view. Eur J Endocrinol 155: S39-S45 [Abstract] [Full Text]  
• Visser-van Balen, H, Sinnema, G, Geenen, R (2006). Growing up with idiopathic short stature: psychosocial development and hormone treatment; a critical review.. Arch. Dis. Child. 91: 433-439 [Abstract] [Full Text]  
• Cuttler, L. (2005). Safety and Efficacy of Growth Hormone Treatment for Idiopathic Short Stature. J. Clin. Endocrinol. Metab. 90: 5502-5504 [Full Text]  
• Ross, J. L., Sandberg, D. E., Rose, S. R., Leschek, E. W., Baron, J., Chipman, J. J., Cassorla, F. G., Quigley, C. A., Crowe, B. J., Roberts, K., Cutler, G. B. Jr. (2004). Psychological Adaptation in Children with Idiopathic Short Stature Treated with Growth Hormone or Placebo. J. Clin. Endocrinol. Metab. 89: 4873-4878 [Abstract] [Full Text]  
• Mears, B. J. (2004). Ethical Issues Raised by Expanded Access to Growth Hormone. AAP Grand Rounds 12: 14-15 [Full Text]  
• Wheeler, P. G., Bresnahan, K., Shephard, B. A., Lau, J., Balk, E. M. (2004). Short Stature and Functional Impairment: A Systematic Review. Arch Pediatr Adolesc Med 158: 236-243 [Abstract] [Full Text]  
• Cuttler, L., Silvers, J. B. (2004). Growth Hormone Treatment for Idiopathic Short Stature: Implications for Practice and Policy. Arch Pediatr Adolesc Med 158: 108-110 [Full Text]  
• Ulph, F, Betts, P, Mulligan, J, Stratford, R J (2004). Personality functioning: the influence of stature. Arch. Dis. Child. 89: 17-21 [Abstract] [Full Text]  
• Lee, P. A., Kendig, J. W., Kerrigan, J. R. (2003). Persistent Short Stature, Other Potential Outcomes, and the Effect of Growth Hormone Treatment in Children Who Are Born Small for Gestational Age. Pediatrics 112: 150-162 [Full Text]  
• Lee, M. M. (2003). Is Treatment with a Luteinizing Hormone-Releasing Hormone Agonist Justified in Short Adolescents?. NEJM 348: 942-945 [Full Text]  
• Finkelstein, B. S., Imperiale, T. F., Speroff, T., Marrero, U., Radcliffe, D. J., Cuttler, L. (2002). Effect of Growth Hormone Therapy on Height in Children With Idiopathic Short Stature: A Meta-analysis. Arch Pediatr Adolesc Med 156: 230-240 [Abstract] [Full Text]  
• Oberfield, S. E. (1999). Growth Hormone Use in Normal, Short Children -- A Plea for Reason. NEJM 340: 557-559 [Full Text]  
• Root, A. W. (1998). Does Growth Hormone Have a Role in the Management of Children with Nongrowth Hormone Deficient Short Stature and Intrauterine Growth Retardation?. J. Clin. Endocrinol. Metab. 83: 1067-1069 [Full Text]